Xdemvy Side Effects
Generic name: lotilaner ophthalmic
Medically reviewed by Drugs.com. Last updated on Oct 27, 2024.
Note: This document provides detailed information about Xdemvy Side Effects associated with lotilaner ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Xdemvy.
Applies to lotilaner ophthalmic: ophthalmic solution.
Serious side effects of Xdemvy
Along with its needed effects, lotilaner ophthalmic (the active ingredient contained in Xdemvy) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking lotilaner ophthalmic:
More common side effects
- burning and stinging of the eye
Less common side effects
- blurred vision
- feeling like there is something in your eye
- increased sensitivity of the eyes to light
- swelling, redness, pain, or tenderness of the eyelid
- tearing and irritation of the eye
For healthcare professionals
Applies to lotilaner ophthalmic: ophthalmic solution.
General adverse events
The most frequently reported side effects included instillation site stinging (10%) and burning (10%).[Ref]
Local
- Very common (10% or more): Instillation site stinging (10%) and burning (10%)[Ref]
Ocular
References
1. (2023) "Product Information. Xdemvy (lotilaner ophthalmic)." Tarsus Pharmaceuticals, Inc.
More about Xdemvy (lotilaner ophthalmic)
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic anti-infectives
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Xdemvy side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.